摘要:
This invention provides methods of screening compounds for their ability to alter the production of Aβ (x≥41) alone or in combination with Aβ (x≤40). The methods involve administering compounds to cells, specifically measuring the amounts of Aβ (x≤40) and Aβ (x≥41) produced by the cells, and comparing these amounts to that produced by the cells without administration of the compounds.
摘要:
This invention provides methods of screening compounds for their ability to alter the production of Aβ (x≥41) alone or in combination with Aβ (x≤40). The methods involve administering compounds to cells, specifically measuring the amounts of Aβ (x≤40) and Aβ (x≥41) produced by the cells, and comparing these amounts to that produced by the cells without administration of the compounds.
摘要:
Methods are provided for treating or preventing Alzheimer's disease comprising mucosally administering β-amyloid peptide or a fragment or analog thereof in an oral or other mucosal dosage form. Also disclosed herein are pharmaceutical formulation or dosage forms for use in these methods.
摘要:
This invention provides methods of screening compounds for their ability to alter the production of Aβ (x≥41) alone or in combination with Aβ (x≤40). The methods involve administering compounds to cells, specifically measuring the amounts of Aβ (x≤40) and Aβ (x≥41) produced by the cells, and comparing these amounts to that produced by the cells without administration of the compounds.